Biblio
Export 326 results:
Author Title [ Type] Year Filters: First Letter Of Last Name is I [Clear All Filters]
“Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.”, PLoS One, vol. 5, no. 11, p. e13950, 2010.
, “Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1117-1129, 2018.
, “Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype.”, J Alzheimers Dis, vol. 69, no. 1, pp. 145-156, 2019.
, “GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.”, J Alzheimers Dis, vol. 49, no. 2, pp. 365-75, 2016.
, “Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 51, no. 2, pp. 333-8, 2016.
, “Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1273-1281, 2016.
, “Higher Blood Vitamin C Levels are Associated with Reduction of Apolipoprotein E E4-related Risks of Cognitive Decline in Women: The Nakajima Study.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1289-1297, 2018.
, “Higher Blood Vitamin C Levels are Associated with Reduction of Apolipoprotein E E4-related Risks of Cognitive Decline in Women: The Nakajima Study.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1289-1297, 2018.
, “Higher Blood Vitamin C Levels are Associated with Reduction of Apolipoprotein E E4-related Risks of Cognitive Decline in Women: The Nakajima Study.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1289-1297, 2018.
, “Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 58, no. 3, pp. 747-762, 2017.
, “Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice.”, J Alzheimers Dis, 2024.
, “Hippocampal Subfield Volumetry: Differential Pattern of Atrophy in Different Forms of Genetic Frontotemporal Dementia.”, J Alzheimers Dis, vol. 64, no. 2, pp. 497-504, 2018.
, “Homocysteine and Cerebral Atrophy: The Epidemiology of Dementia in Singapore Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 877-885, 2018.
, “Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 3, pp. 807-16, 2016.
, “Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.”, J Alzheimers Dis, vol. 48, no. 2, pp. 411-24, 2015.
, “Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1015-31, 2016.
, “Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.”, J Alzheimers Dis, 2015.
, “Identification of Physician-Diagnosed Alzheimer's Disease and Related Dementias in Population-Based Administrative Data: A Validation Study Using Family Physicians' Electronic Medical Records.”, J Alzheimers Dis, vol. 54, no. 1, pp. 337-49, 2016.
, “Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 405-15, 2016.
, “Impact of Untimely Access to Formal Care on Costs and Quality of Life in Community Dwelling People with Dementia.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1165-1174, 2018.
, “Impaired Autophagy in APOE4 Astrocytes.”, J Alzheimers Dis, vol. 51, no. 3, pp. 915-27, 2016.
, “Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 67, no. 2, pp. 639-651, 2019.
, “In Vivo Amyloid, Neurodegeneration, and Verbal Learning in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 82, no. 1, pp. 317-325, 2021.
, “In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1355-1365, 2018.
, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1037-1052, 2018.
,